Info

A paper on a groundbreaking drug discovery modality using technology developed by EditForce Inc., a biotech venture founded by Professor Takahiro Nakamura (Faculty of Agriculture), sub-leader of the Environment and Food Unit, has been published in Science Translational Medicine. This is a historic achievement, even on a global scale, in linking knowledge of plant science to drug discovery research.

Imai et al., Pentatricopeptide repeat protein targeting CUG repeat RNA ameliorates RNA toxicity in a myotonic dystrophy type 1 mouse model. Sci Transl Med. 17 (2025).